Schering AG dermatology business “Intendis”
Executive Summary
Schering AG names separate dermatology business group Intendis. Company will formally begin operations Jan. 1. U.S. headquarters in Montville, N.J. will house about 70 out of approximately 600 global Intendis employees. Managing Director Wolfgang Kehr will lead global headquarters in Berlin. U.S. management will include North & Latin America Marketing & Sales head Bernhard Schefter. Schering announced in June it was spinning off "non-core" businesses to focus on oncology (1"The Pink Sheet" June 21, 2004, p. 38)....
You may also be interested in...
Schering AG Makes Oncology A Primary Focus; Dermatology No Longer “Core”
Schering AG is establishing a new global oncology business unit that will be headquartered in the U.S
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.